Title:
PRODRUG OF JAK KINASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/041586
Kind Code:
A1
Abstract:
The present invention relates to a prodrug containing a JAK inhibitor, a composition, and use thereof . In particular, the present invention relates to a compound represented by formula (II), a pharmaceutical composition containing the compound of the present invention, and use thereof as a JAK inhibitor prodrug in treating inflammatory diseases and tumor-related diseases.
Inventors:
LIU PENGFEI (CN)
SHEN WANG (CN)
BAI RUJUN (CN)
DING YUE (CN)
DING SHIZHE (CN)
SHEN WANG (CN)
BAI RUJUN (CN)
DING YUE (CN)
DING SHIZHE (CN)
Application Number:
PCT/CN2023/114558
Publication Date:
February 29, 2024
Filing Date:
August 24, 2023
Export Citation:
Assignee:
E NITIATE BIOPHARMACEUTICALS HANGZHOU CO LTD (CN)
International Classes:
C07D471/14; A61K31/437; A61P35/00; A61P37/00
Domestic Patent References:
| WO2013007765A1 | 2013-01-17 | |||
| WO2022006457A1 | 2022-01-06 |
Foreign References:
| CN110724142A | 2020-01-24 | |||
| CN113292561A | 2021-08-24 | |||
| CN114149428A | 2022-03-08 | |||
| CN102395589A | 2012-03-28 |
Download PDF:
Previous Patent: A METHOD FOR PLACE RECOGNITION ON 3D POINT CLOUD
Next Patent: PHARMACEUTICAL COMPOSITION OF ANTIBODY DRUG CONJUGATE
Next Patent: PHARMACEUTICAL COMPOSITION OF ANTIBODY DRUG CONJUGATE